Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling

Molecular and Cellular Biology

Volumn 31, Issue 23, 2011, Pages 4663-4675

  Galliher Beckley, Amy Jo ^a   Williams, Jason Grant ^b   Cidlowski, John Anthony ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; GLUCOCORTICOID RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE;

ARTICLE; CELL FUNCTION; CELL STRESS; CELLULAR STRESS SIGNAL; CHROMATIN; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; STIMULUS;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; CELL LINE, TUMOR; DEXAMETHASONE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; IMIDAZOLES; IMMUNOPRECIPITATION; LIGANDS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; PYRIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID; SERINE; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 83255187892     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05866-11     Document Type: Article

References (48)

1. Adcock, I. M., K. Ito, and P. J. Barnes. 2004. Glucocorticoids: effects on gene transcription. Proc. Am. Thorac. Soc. 1:247-254.
2. Anagnostis, P., V. G. Athyros, K. Tziomalos, A. Karagiannis, and D. P. Mikhailidis. 2009. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94:2692-2701.
3. Barnes, P. J., and I. M. Adcock. 2009. Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905-1917.
4. Blind, R. D., and M. J. Garabedian. 2008. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J. Steroid Biochem. Mol. Biol. 109:150-157.
5. Boulon, S., B. J. Westman, S. Hutten, F. M. Boisvert, and A. I. Lamond. 2010. The nucleolus under stress. Mol. Cell 40:216-227.
6. Cassel, T. N., and M. Nord. 2003. C/EBP transcription factors in the lung epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L773-L781.
7. Chen, W., et al. 2008. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol. Endocrinol. 22:1754-1766.
8. Chen, W., I. Rogatsky, and M. J. Garabedian. 2006. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol. Endocrinol. 20:560-572.
9. Chrousos, G. P. 2009. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5:374-381.
10. Cidlowski, J. A., D. L. Bellingham, F. E. Powell-Oliver, D. B. Lubahn, and M. Sar. 1990. Novel antipeptide antibodies to the human glucocorticoid receptor: recognition of multiple receptor forms in vitro and distinct localization of cytoplasmic and nuclear receptors. Mol. Endocrinol. 4:1427-1437.
11. Coulthard, L. R., D. E. White, D. L. Jones, M. F. McDermott, and S. A. Burchill. 2009. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 15:369-379.
12. Dephoure, N., et al. 2008. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 105:10762-10767.
13. Edgar, R., M. Domrachev, and A. E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30:207-210.
14. El Mjiyad, N., A. Caro-Maldonado, S. Ramirez-Peinado, and C. Munoz-Pinedo. 2011. Sugar-free approaches to cancer cell killing. Oncogene 30:253-264.
15. Galliher-Beckley, A. J., and J. A. Cidlowski. 2009. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life 61:979-986.
16. Galliher-Beckley, A. J., J. G. Williams, J. B. Collins, and J. A. Cidlowski. 2008. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol. Cell. Biol. 28:7309-7322.
17. Garza, A. M., S. H. Khan, and R. Kumar. 2010. Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered Nterminal activation function (AF1) domain of the glucocorticoid receptor. Mol. Cell. Biol. 30:220-230.
18. Glass, C. K., and K. Saijo. 2010. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 10:365-376.
19. Gross, K. L., and J. A. Cidlowski. 2008. Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol. Metab. 19:331-339.
20. Hayashi, R., H. Wada, K. Ito, and I. M. Adcock. 2004. Effects of glucocorticoids on gene transcription. Eur. J. Pharmacol. 500:51-62.
21. Huang, L. 2006. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. J. Cell. Physiol. 209:611-616.
22. Irusen, E., et al. 2002. p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109:649-657.
23. Ismaili, N., and M. J. Garabedian. 2004. Modulation of glucocorticoid receptor function via phosphorylation. Ann. N. Y. Acad. Sci. 1024:86-101.
24. Junttila, M. R., S. P. Li, and J. Westermarck. 2008. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22:954-965.
25. Kim, Y. S., et al. 2005. Role of 14-3-3 eta as a positive regulator of the glucocorticoid receptor transcriptional activation. Endocrinology 146:3133-3140.
26. Kino, T., et al. 2007. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol. Endocrinol. 21:1552-1568.
27. Kino, T., et al. 2003. Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J. Biol. Chem. 278:25651-25656.
28. Kyriakis, J. M., and J. Avruch. 1996. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18:567-577.
29. Le Drean, Y., N. Mincheneau, P. Le Goff, and D. Michel. 2002. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143:3482-3489.
30. Lu, N. Z., and J. A. Cidlowski. 2005. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 18:331-342.
31. Maiese, K., Z. Z. Chong, and Y. C. Shang. 2008. OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol. Med. 14:219-227.
32. Miller, A. L., et al. 2005. p38 mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol. Endocrinol. 19:1569-1583.
33. Necela, B. M., and J. A. Cidlowski. 2004. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc. Am. Thorac. Soc. 1:239-246.
34. Oakley, R. H., and J. A. Cidlowski. 2010. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissuespecific actions of glucocorticoids. J. Biol. Chem. 286:3177-3184.
35. Ogihara, T., et al. 1997. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J. Biol. Chem. 272:25267-25274.
36. Poetker, D. M., and D. D. Reh. 2010. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol. Clin. North Am. 43:753-768.
37. Rose, A. J., A. Vegiopoulos, and S. Herzig. 2010. Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J. Steroid Biochem. Mol. Biol. 122:10-20.
38. Rosmond, R. 2005. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 30:1-10.
39. Schieven, G. L. 2009. The p38alpha kinase plays a central role in inflammation. Curr. Top. Med. Chem. 9:1038-1048.
40. Smith, L. K., R. R. Shah, and J. A. Cidlowski. 2010. Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J. Biol. Chem. 285:36698-36708.
41. Smoak, K. A., and J. A. Cidlowski. 2004. Mechanisms of glucocorticoid receptor signaling during inflammation. Mech. Ageing Dev. 125:697-706.
42. Trujillo, M. E., et al. 2006. Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein kinase. J. Clin. Endocrinol. Metab. 91:1484-1490.
43. Wallace, A. D., and J. A. Cidlowski. 2001. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276:42714-42721.
44. Webster, J. C., et al. 1997. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 272:9287-9293.
45. Xing, H., S. Zhang, C. Weinheimer, A. Kovacs, and A. J. Muslin. 2000. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19:349-358.
46. Yong, H. Y., M. S. Koh, and A. Moon. 2009. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin. Invest. Drugs 18:1893-1905.
47. Yu, D., et al. 2010. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev. 24:1620-1633.
48. Yu, D., and C. G. Vinuesa. 2010. Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity. Cell. Mol. Immunol. 7:198-203.